Cargando…

The effects of Maraviroc on liver fibrosis in HIV/HCV co-infected patients

INTRODUCTION: The fibrogenesis analysis in quimeric CCR1 and CCR5 mice revealed that CCR5 mediates its pro-fibrogenic effects in hepatic cells and promoting stellate cells. The blockage of co-receptors could preserve the progression of hepatic fibrosis in HIV/HCV co-infected patients. OBJECTIVE: To...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ortega Gonzalez, Enrique, Boix, Vicente, Garcia Deltoro, Miguel, Lopez Aldeguer, Jose, Portilla, Joaquin, Montero, Marta, Ballester Belda, Emilio, Abril, Vicente, Gutierrez, Felix, Minguez, Carlos, Galindo, Josefa, Benirto, Concepcion, Garcia Rodriguez, Magdalena, Giner, Livia, Rubio, Purificacion, Uso, Jorge, Llerena, Giovanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P111
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224825/ https://www.ncbi.nlm.nih.gov/pubmed/25394147 http://dx.doi.org/10.7448/IAS.17.4.19643

Ejemplares similares

Development of a Large Animal Model of Osteochondritis Dissecans of the Knee: A Pilot Study
por: Pfeifer, Christian G., et al.
Publicado: (2015)

Greater Polar Moment of Inertia at the Tibia in Athletes Who Develop Stress Fractures
por: Weidauer, Lee A., et al.
Publicado: (2014)

Telaprevir or boceprevir in HIV/HCV-1 co-infected patients in a real-life setting. Interim analysis (24 weeks). COINFECOVA-SEICV study
por: Minguez, Carlos, et al.
Publicado: (2014)

Manifestations cutanées au cours l’épidémie de COVID-19 : étude COVID-Skin de la Société française de dermatologie
por: Guelimi, R., et al.
Publicado: (2020)

Profiles of elemental concentrations in human: contribution of X-ray fluorescence to discrimination between healthy and diseased tissues and prediction of alterations in tongue carcinoma
por: Zagalo, Luísa, et al.
Publicado: (2021)

Safety and therapeutic efficacy of the switch to maraviroc+darunavir/ritonavir in HIV/HCV coinfected patients: initial results from GUSTA study
por: Gagliardini, Roberta, et al.
Publicado: (2014)

Use of maraviroc in patients with undetectable viral load: efficacy, tolerance and predictors of viral response in MARAVIROC-cohort study
por: Jesús Pérez Elías, María, et al.
Publicado: (2014)

Role of maraviroc in a dyslipidemic murine model of atherosclerosis RTV-induced
por: Cipriani, S, et al.
Publicado: (2012)

Dual therapy with darunavir/r plus etravirine is safe and effective as switching therapy in antiretroviral experienced HIV-patients. The BITER Study
por: Portilla, Joaquín, et al.
Publicado: (2014)

Postural orthostatic tachycardia syndrome associated with post-acute covid-19 syndrome is not mediated through smaller hearts or contractile dysfunction
por: Ahmad, A, et al.
Publicado: (2023)

Novel inflammatory biomarkers in postural orthostatic tachycardia syndrome
por: Nawaz, S, et al.
Publicado: (2023)

Improvement of endothelial function after switching previously treated HIV-infected patients to an NRTI-sparing bitherapy with maraviroc
por: Bernal, Enrique, et al.
Publicado: (2014)

Screening for HCV infection combined with SARS-CoV-2 vaccination in the Campania region
por: Torre, P., et al.
Publicado: (2022)

Implementation of hcv screening in the 1969-1989 birth-cohort undergoing covid-19 vaccination: a pivotal study in Italy
por: D'Ambrosio, R., et al.
Publicado: (2022)

Towards an HIV cure
por: Deeks, Steven
Publicado: (2014)

Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study
por: Garcia, Federico, et al.
Publicado: (2014)

Bone mineral density improvement after 48 weeks of switch to maraviroc+darunavir/ritonavir 300/800/100 mg QD, preliminary results of GUSTA study
por: Bianco, Claudia, et al.
Publicado: (2014)

Analysis of hepatitis non-treatment causes in a cohort of HCV and HCV/HIV infected patients
por: Pereira, Karen, et al.
Publicado: (2014)

Maraviroc in the treatment of HIV infection
por: Ray, Neelanjana
Publicado: (2009)

Evaluation of the degree of liver fibrosis and genetical characteristics in HIV patients with spontaneous clearance of HCV in Cartagena, Spain
por: Jesús Vera Méndez, Francisco, et al.
Publicado: (2014)

HCV triple therapy in co-infection HIV/HCV is not associated with a different risk of developing major depressive disorder
por: Fialho, Renata, et al.
Publicado: (2014)

Safety analysis of raltegravir/truvada regimen in HIV/HCV co-infected patients without switchback after HCV treatment
por: Ehret, Robert, et al.
Publicado: (2014)

Improve screening of HCV infection by targeting high prevalence aged groups: analysis of a cohort of HCV and HIV co-infected patients
por: Brogueira, Pedro, et al.
Publicado: (2014)

Hepatic safety of RPV/FTC/TDF single tablet regimen in HIV/HCV-coinfected patients. Preliminary results of the hEPAtic Study
por: Neukam, Karin, et al.
Publicado: (2014)

Dimensional structure of the oral health-related quality of life in healthy Spanish workers
por: Montero, Javier, et al.
Publicado: (2010)

Appearance of NS3 Q80K mutation in HCV genotype 1a mono- or HIV/HCV co-infected patients in a Berlin laboratory
por: Ehret, Robert, et al.
Publicado: (2014)

Lp-PLA2 levels in HIV-infected patients
por: Díaz-Pollán, Beatriz, et al.
Publicado: (2014)

Maraviroc: the evidence for its potential in the management of HIV
por: Profit, Louise
Publicado: (2007)

Detection of response shift in health-related quality of life studies: a systematic review
por: Ortega-Gómez, Estelina, et al.
Publicado: (2022)

Estimating the effect of emotional intelligence in wellbeing among priests
por: Vicente-Galindo, María Purificación, et al.
Publicado: (2017)

Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients
por: Gonzalez-Serna, Alejandro, et al.
Publicado: (2016)

Guerra de Yugurta ; Fragmentos de las historias ; Cartas a César sobre el gobierno de la República
por: Salustio, 86-34 a.C
Publicado: (1945)

Is HCV elimination possible in prison?
por: Crespo, J., et al.
Publicado: (2017)

Efficacy and tolerability of telaprevir (TVR)-based triple therapy in HIV/HCV-coinfected patients
por: De Los Santos, Ignacio, et al.
Publicado: (2014)

Data-Mining Techniques: A New Approach to Identifying the Links among Hybrid Strains of Pleurotus with Culture Media
por: Guevara-Viejó, Fabricio, et al.
Publicado: (2021)

Application of K-Means Clustering Algorithm to Commercial Parameters of Pleurotus spp. Cultivated on Representative Agricultural Wastes from Province of Guayas
por: Guevara-Viejó, Fabricio, et al.
Publicado: (2021)

An Experimental and Numerical Investigation to Characterize an Aerospace Composite Material with Open-Hole Using Non-Destructive Techniques
por: Feito, Norberto, et al.
Publicado: (2020)

Effect of HIV infection-related factors on SVR rate in HCV treatment in HIV-infected patients
por: Kravchenko, Alexey, et al.
Publicado: (2014)

Implications of maraviroc and/or rapamycin in a mouse model of fragility
por: Pérez-Martínez, Laura, et al.
Publicado: (2020)

Alarming increase in tuberculosis and hepatitis C virus (HCV) among HIV infected intravenous drug users
por: Oprea, Cristiana, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c1hja865e8kmjv519dldh6p418